Dr Anjana Aggarwal
Dr Anjana Aggarwal has over 9 years’ experience as a Senior Pharmaceutical Assessor at the MHRA and is an EMA Quality Expert.
At the MHRA, Dr Aggarwal reviewed CMC dossiers for initial applications and post-approval variations (National, MR/DCP, Centralised) and CHMP/MHRA scientific advice, including: fermentation products, drug-device combinations, small peptides, herbal products, various dosage forms (including liposomal, prolonged and modified release preparations), QbD applications, and bioequivalence studies.
An invited speaker at numerous international conferences including events by TOPRA, Informa, Joint Pharmaceutical Analysis Group (JPAG) and CPhI, Dr Aggarwal specialises in Quality by Design applications and variations and liposomal formulations, with principal therapeutic areas including oncology, musculoskeletal and other malignant diseases. She is a UK-registered pharmacist with both community and hospital experience and a member of the Royal Pharmaceutical Society and the International Society for Pharmaceutical Engineering.